Amundi FTSE EPRA NAREIT Global UCITS ETF Acc (EPRA)

That is a good question: Will Netlist be included in the development of next generation memory?
Can these companies just wait out Netlist until thry are not in the mix? Then not worry about paying royalities?

We all remember Black Berry phones. They were once, not to long ago

You will find several clues in this post:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177331519

👉👉LATEST $RKT PPS targets==>Jefferies:$25, Oppenheimer:$25, BTIG:$25, Stephens:$22.50, Goldman Sachs:$22, KBW:$21, Compass Point:$21, RBC Capital:$20, Barclays:$19, BofA:$18, Morgan Stanley:$18, Wells Fargo:$17, UBS:$17, JPMorgan:$16.50

Seems I'm one of the few posting - it would be nice to have counter views?
Here’s the interesting thing: If the DLA’s previous Request for Information (RFI) definitively established that no other domestic entity exists to fill this specific midstream refining gap, then the traditional bureauc

So you're not arguing against a point, just my verbiage.

And you're missing the point. It's because DCVax-L isn't in the category that we have no framework for seeing an approval.

Therefore, order to get the tissue-agnostic approval that some (not you) are hoping/anti

SN5, I agree with what you said about the new product and future, but I did have a statement / question. I believe CVS Caremark still has Vascepa as preferred in the cardiovascular space. However, on the CVS pharmacy side, they many times substitute a generic. ?? I could be wrong.
Thanks

Reddit Tomkila: Netlist pressure on mrdimm, lrdimm ddr4, ddr5 & hbm dram products. sk hynix knows that hbm products alone can be worth billions of dollars in damages.

$SNTX wait until the price drops below a penny before you all buy in ?
don't just let the dozen or so insiders make all the money , they already know when to sell ?
its just like when $gtvh touched 0036 price and then dropped to 001 like a rock ............insiders were tol

$NCRA Nocera Announces Strategic Transformation into Nocera Holdings, Expanding Across Artificial Intelligence, Data Centers, Robotics, Biotech and Digital Assets; Company Expands Strategic Vision Following Amendment of up to $300 Million Facility to Pursue Acquisitions, Partnerships and Investments

$NCRA Nocera Announces Strategic Transformation into Nocera Holdings, Expanding Across Artificial Intelligence, Data Centers, Robotics, Biotech and Digital Assets; Company Expands Strategic Vision Following Amendment of up to $300 Million Facility to Pursue Acquisitions, Partnerships and Investments

LBGJ, $1.2, Low O/S: 1.8 m.

$MAJI NexTel Medical, Penn State start mushroom exosome study
*Collaborative exosome characterization study launched with Pennsylvania State University
*Use of advanced mass spectrometry to map mushroom exosome bioactive compounds
*Preliminary findings already driving new IP and

$MAJI NexTel Medical, Penn State start mushroom exosome study
*Collaborative exosome characterization study launched with Pennsylvania State University
*Use of advanced mass spectrometry to map mushroom exosome bioactive compounds
*Preliminary findings already driving new IP and

Our Merger & Acquisition partner is working on finding us a suitor. If an acceptable offer is presented today, we’ll be more than happy to consider it. But if not, we will wait another quarter or two to show realistic revenues and profits that include Lisdex and show the trending for the sales of Li

ok ATLnsider- I ask for a challenge question. Since you were correct on the 1st clinical trial using Dr. P Kalinski treatment, what do you expect the next two clinical trials from NWBO????

Just wait for next earnings call.
https://www.youtube.com/watch?v=30MV9Yu2MQw

$AMPX makes the batteries🔋 and cells,🔋 Titan power takes those cells🔋 and batteries🔋 and puts them in packs,🔋🔋🔋🔋🔋🔋🤓 in the USA and sel

And those shares are representative of an investment by someone, likely company insiders. Insiders can't help themselves, with Amprius again as an example, they sell their stock. Bottom line is that the group here has a snowball's chance if Endurion fails. The portion we have of the underwhelming co

The experts got in before Expert Market ;). 
As my friend said ‘genius or idiot’…  let’s see where we land. 

Not going to be around today but picked a few of these here ...

>

Of course he did.

The Serial Liar CEO had to know multi-tons in 2025 was out of reach.

He had to know that the 10,000 lbs of finished spider-ish silk yarn in 2025 was out of reach.

CCTG, $2.5, bought at $0.63 yesterday.

Just keep holding and stay focused on the bigger picture. After this update, some of yesterday’s sellers may be second-guessing their decision. But that’s how the market works—every investor has to make their own call. Haha.

Sounds like growth and acquisitions to me, hopefully. ☺️

Market still sleeping on the scope here.
Most traders see “small-cap Web3 company.”But the company is trying to build sovereign-scale infrastructure across emerging markets. Big difference. 🌍
If execution continues: DRCPass + Ghana initiatives + Ripple ecosystem integration + W